3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Lung Neoplasms
5
Radiation Injuries
2
Head and Neck Neoplasms
2
Glioblastoma
2
Esophageal Neoplasms
2
Cardiotoxicity
2
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Tobacco Use Disorder
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Smoking
1
Rectal Neoplasms
1
Ototoxicity
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Lymphatic Metastasis
1
Locally Advanced Cervical Cancer
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Heart Diseases
1
Hearing Loss
1
Cognitive Dysfunction
1
Cholangiocarcinoma
1
Cardiovascular Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery
1
Interventions
Counseling
2
phenanthrene tetraol
1
phenanthrene
1
Varenicline
1
Tobacco Use Cessation Devices
1
Surveys and Questionnaires
1
Spectroscopy, Fourier Transform Infrared
1
Radiotherapy
1
Immunohistochemistry
1
Chemoradiotherapy
1
4-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Tobacco Use Disorder
×
Chemoradiotherapy
×
Clear all
NCT06910566
2026-03-18
TABAC STOP ORL
Centre Oscar Lambret
Active not recruiting
100 enrolled